TEST BANK
ADVANCED ASSESSMENT: INTERPRETING
FINDINGS AND FORMULATING
DIFFERENTIAL DIAGNOSES
,TABLE OF CONTENTS
Part I: The Art of Assessment and Clinical Decision Making
Chapter 1. Clinical Decision Making: Assessment and Differential Diagnosis
Chapter 2. Diagnostic Studies
Chapter 3. Genomic Assessment: Interpreting Findings and Formulating Differential Diagnoses
Part II: Advanced Assessment and Differential Diagnosis by Body Regions and Systems
Chapter 4. Skin
Chapter 5. Head, Face, and Neck
Chapter 6. Eyes
Chapter 7. Ear, Nose, Mouth, and Throat
Chapter 8. Cardiac and Peripheral Vascular Systems
Chapter 9. Respiratory System
Chapter 10. Breasts
Chapter 11. Abdomen
Chapter 12. Genitourinary System
Chapter 13. Male Reproductive System
Chapter 14. Female Reproductive System
Chapter 15. Musculoskeletal System
Chapter 16. Neurological System
Chapter 17. Nonspecific Complaints
Chapter 18. Psychiatric Mental Health
Part III: Assessment and Differential Diagnosis in Special Patient Populations
Chapter 19. Pediatric Patients
Chapter 20. Pregnant Patients
Chapter 21. Assessment of Transgender and Gender-Diverse Adults
Chapter 22. Older Patients
Chapter 23. Persons With Disabilities
, Chapter 1. . Clinical Decision Making: Assessment and Differential Diagnosis
➢
Multiple Choice
Identify The Choice That Best Completes The Statement Or Answers The Question.
1. Which type of clinical decision-making is most reliable?
A. Intuitive
B. Analytical
C. Experiential
D. Augenblick
2. Which of the following is false? To obtain adequate history, health-care providers must be:
A. Methodical and systematic
B. Attentive to the patient’s verbal and nonverbal
Language
C. Able to accurately interpret the patient’s
responses
D. Adept at reading into the patient’s statements
3. Essential parts of a health history include all of the following except:
A. Chief complaint
B. History of the present illness
C. Current vital signs
D. All of the above are essential history
components
4. which of the following is false? While performing the physical examination, the examiner must be able to:
A. Differentiate between normal and abnormal findings
B. Recall knowledge of a range of conditions and their associated signs and
symptoms
C. Recognize how certain conditions affect the response to other
conditions
D. Foresee unpredictable findings
5. The following is the least reliable source of information for diagnostic statistics:
A. Evidence-based investigations
B. Primary reports of research
C. Estimation based on a provider’s
experience
D. Published meta-analyses
6. The following can be used to assist in sound clinical decision-making:
A. Algorithm published in a peer-reviewed journal
article
B. Clinical practice guidelines
C. Evidence-based research
D. All of the above
7. If a diagnostic study has high sensitivity, this indicates a:
A. High percentage of persons with the given condition will have an
abnormal
Result
B. Low percentage of persons with the given condition will have an
abnormal result
C. Low likelihood of normal result in persons without a given condition
D. None of the above
8. if a diagnostic study has high specificity, this indicates a:
A. Low percentage of healthy individuals will show a normal result
B. High percentage of healthy individuals will show a normal result
C. High percentage of individuals with a disorder will show a
normal result
D. Low percentage of individuals with a disorder will show an
abnormal
Result
9. a likelihood ratio above 1 indicates that a diagnostic test showing a:
A. Positive result is strongly associated with the disease
B. Negative result is strongly associated with absence of
the disease
C. Positive result is weakly associated with the disease
D. Negative result is weakly associated with absence of the
disease
, 10. which of the following clinical reasoning tools is defined as evidence-based resource based on
mathematical modeling to express the likelihood of a condition in select situations, settings, and/or
patients?
A. Clinical practice
guideline
B. Clinical decision rule
C. Clinical algorithm
Chapter 1: clinical reasoning, differential diagnosis, evidence-based practice, and symptom ana
Answer section
Multiple choice
1. Answer: b
Croskerry (2009) describes two major types of clinical diagnostic decision-making: intuitive and analytical.
Intuitive decision-making (similar to augenblink decision-making) is based on the experience and
intuition of the clinician and is less reliable andpaired with fairly common errors. In contrast, analytical
decision-making is based on careful consideration and has greater reliability with rare errors.
Pts: 1
2. Answer: d
To obtain adequate history, providers must be well organized, attentive to the patient’s verbal and
nonverbal language, and ableto accurately interpret the patient’s responses to questions. Rather than
reading into the patient’s statements, they clarify any areas of uncertainty.
Pts: 1
3. Answer: C
Vital signs are part of the physical examination portion of patient assessment, not part of the
health history.
Pts: 1
4. Answer: D
While performing the physical examination, the examiner must be able to differentiate between normal
and abnormal findings, recall knowledge of a range of conditions, including their associated signs and
symptoms, recognize how certain conditions affectthe response to other conditions, and distinguish the
relevance of varied abnormal findings.
Pts: 1
5. Answer: c
Sources for diagnostic statistics include textbooks, primary reports of research, and published meta-
analyses. Another source of statistics, the one that has been most widely used and available for application
to the reasoning process, is the estimation based ona provider’s experience, although these are rarely
accurate. Over the past decade, the availability of evidence on which to base clinical reasoning is improving,
and there is an increasing expectation that clinical reasoning be based on scientific evidence.
Evidence-based statistics are also increasingly being used to develop resources to facilitate clinical decision-making.
Pts: 1
6. Answer: d
To assist in clinical decision-making, a number of evidence-based resources have been developed to
assist the clinician. Resources, such as algorithms and clinical practice guidelines, assist in clinical
reasoning when properly applied.
Pts: 1
7. Answer: a
The sensitivity of a diagnostic study is the percentage of individuals with the target condition who show an
abnormal, or positive,result. A high sensitivity indicates that a greater percentage of persons with the given
condition will have an abnormal result.
Pts: 1
8. Answer: b
The specificity of a diagnostic study is the percentage of normal, healthy individuals who have a normal
result. The greater the specificity, the greater the percentage of individuals who will have negative, or
normal, results if they do not have the target condition.
Pts: 1
,9. Answer: a
The likelihood ratio is the probability that a positive test result will be associated with a person who has
the target condition and a negative result will be associated with a healthy person. A likelihood ratio above 1
indicates that a positive result is associated with the disease; a likelihood ratio less than 1 indicates that a
negative result is associated with an absence of the disease.
Pts: 1
10. Answer: b
Clinical decision (or prediction) rules provide another support for clinical reasoning. Clinical decision
rules are evidence-based resources that provide probabilistic statements regarding the likelihood that a
condition exists if certain variables are met with regard to the prognosis of patients with specific
findings. Decision rules use mathematical models and are specific to certain situations, settings,
and/or patient characteristics.
Pts: 1
,CHAPTER 2: DIAGNOSTIC STUDIES
SECTION A: MULTIPLE-CHOICE QUESTIONS (25 Questions)
EASY LEVEL (Questions 1–9)
Question 1.
What is the primary purpose of ordering diagnostic studies in advanced practice?
A. To replace the need for a thorough history and physical examination
B. To confirm or refute clinical hypotheses generated from the history and physical examination, thereby narrowing the differential
diagnosis
C. To order as many tests as possible to ensure no diagnosis is missed
D. To satisfy patient expectations regardless of clinical indication
Answer: B
Rationale: Diagnostic studies are an adjunct to—not a replacement for—the clinical encounter. The advanced practice clinician
formulates a differential diagnosis based on the history and physical examination, then selectively orders diagnostic tests to
confirm, refine, or exclude specific diagnoses. Indiscriminate test ordering ("shotgun approach") increases the risk of false-positive
results, unnecessary follow-up procedures, patient anxiety, and health care costs without improving diagnostic accuracy.
Question 2.
Which of the following best defines the "sensitivity" of a diagnostic test?
A. The proportion of patients without the disease who correctly test negative
B. The proportion of patients with the disease who correctly test positive (true positive rate)
C. The probability that a patient with a positive test actually has the disease
D. The probability that a patient with a negative test truly does not have the disease
Answer: B
Rationale: Sensitivity is the ability of a test to correctly identify individuals who HAVE the disease (true positive rate). It is
calculated as: Sensitivity = True Positives / (True Positives + False Negatives). A highly sensitive test is valuable for ruling
OUT disease when the result is negative (mnemonic: SnNOut — Sensitive test, Negative result, rules Out disease). Specificity
(Option A) is the true negative rate. Positive predictive value (Option C) and negative predictive value (Option D) describe post-
test probabilities.
Question 3.
Which of the following best defines the "specificity" of a diagnostic test?
A. The proportion of patients with the disease who correctly test positive
B. The ability of a test to correctly identify individuals who do NOT have the disease (true negative rate)
C. The likelihood that a positive test result is a true positive
D. The overall accuracy of the test across all populations
Answer: B
Rationale: Specificity is the ability of a test to correctly identify individuals who do NOT have the disease (true negative rate). It is
calculated as: Specificity = True Negatives / (True Negatives + False Positives). A highly specific test is valuable for ruling
IN disease when the result is positive (mnemonic: SpPIn — Specific test, Positive result, rules In disease). A test with high
specificity has a low false-positive rate.
Question 4.
A complete blood count (CBC) with differential is ordered for a patient presenting with fatigue and pallor. Which component of the
CBC is most directly relevant to evaluating for anemia?
A. White blood cell (WBC) count
B. Platelet count
C. Hemoglobin (Hgb) and hematocrit (Hct)
D. Mean platelet volume (MPV)
Answer: C
Rationale: Hemoglobin and hematocrit are the primary CBC parameters used to diagnose and classify anemia. Anemia is defined
as a hemoglobin level below the age- and sex-adjusted reference range (generally <13.5 g/dL in adult males, <12.0 g/dL in adult
females). The WBC count evaluates for infection, inflammation, or hematologic malignancy. Platelet count assesses
thrombocytopenia or thrombocytosis. MPV reflects platelet size and is relevant to platelet production disorders.
Question 5.
,Which laboratory test is the most sensitive initial screening test for thyroid dysfunction?
A. Free T4 (thyroxine)
B. Total T3 (triiodothyronine)
C. Thyroid-stimulating hormone (TSH)
D. Thyroid peroxidase antibodies (TPO-Ab)
Answer: C
Rationale: TSH is the single most sensitive screening test for thyroid dysfunction because of the logarithmic inverse relationship
between TSH and circulating thyroid hormone levels. Even small changes in free T4 produce large, amplified changes in TSH due
to the negative feedback loop of the hypothalamic-pituitary-thyroid axis. In primary hypothyroidism, TSH rises before free T4 falls
below the reference range (subclinical hypothyroidism). In primary hyperthyroidism, TSH is suppressed before free T4 rises above
the reference range. Free T4 and T3 are ordered as follow-up tests when TSH is abnormal.
Question 6.
A basic metabolic panel (BMP) includes all of the following EXCEPT:
A. Blood urea nitrogen (BUN)
B. Creatinine
C. Alanine aminotransferase (ALT)
D. Glucose
Answer: C
Rationale: The Basic Metabolic Panel (BMP) includes 8 tests: sodium, potassium, chloride, CO₂ (bicarbonate), BUN, creatinine,
glucose, and calcium. ALT is a liver enzyme included in the Comprehensive Metabolic Panel (CMP) or Hepatic Function Panel,
NOT the BMP. The CMP includes all 8 BMP tests plus 6 additional tests: total protein, albumin, alkaline phosphatase (ALP), ALT,
AST, and total bilirubin.
Question 7.
Which of the following urinalysis findings is most suggestive of a urinary tract infection (UTI)?
A. Specific gravity of 1.010
B. pH of 6.0
C. Positive leukocyte esterase and nitrites with microscopic pyuria (>10 WBCs/hpf)
D. Trace protein
Answer: C
Rationale: The classic urinalysis triad for UTI includes: (1) Positive leukocyte esterase (indicating the presence of WBC enzyme
from neutrophils), (2) Positive nitrites (indicating the presence of nitrate-reducing gram-negative bacteria such as E. coli), and
(3) Microscopic pyuria (>10 WBCs per high-power field). While isolated findings may be nonspecific, the combination of all
three has high positive predictive value for bacterial UTI. Trace protein and normal pH/specific gravity are nonspecific findings.
Question 8.
What does an elevated C-reactive protein (CRP) level indicate?
A. Specific diagnosis of rheumatoid arthritis
B. Acute or chronic systemic inflammation (nonspecific acute-phase reactant)
C. Bacterial infection exclusively
D. Liver failure
Answer: B
Rationale: CRP is a nonspecific acute-phase reactant synthesized by the liver in response to interleukin-6 (IL-6) and other
proinflammatory cytokines. It rises rapidly within 6–8 hours of an inflammatory stimulus and can be elevated in a wide range of
conditions: bacterial and viral infections, autoimmune diseases, tissue injury, malignancy, and cardiovascular disease. CRP does
NOT identify the specific cause or location of inflammation. High-sensitivity CRP (hs-CRP) is used for cardiovascular risk
stratification, while standard CRP is used for monitoring inflammatory and infectious conditions.
Question 9.
Which coagulation test is used to monitor warfarin (Coumadin) therapy?
A. Activated partial thromboplastin time (aPTT)
B. Prothrombin time (PT) and International Normalized Ratio (INR)
C. Bleeding time
D. D-dimer
Answer: B
Rationale: The PT/INR is the standard test for monitoring warfarin anticoagulation therapy. Warfarin inhibits vitamin K–
dependent clotting factors (II, VII, IX, X), which are measured by the PT. The INR standardizes PT results across different
laboratories and reagent sensitivities. The therapeutic INR range is typically 2.0–3.0 for most indications (e.g., atrial fibrillation,
,DVT/PE) and 2.5–3.5 for mechanical heart valves. The aPTT (Option A) monitors unfractionated heparin therapy. D-dimer
(Option D) is used to evaluate for venous thromboembolism.
MEDIUM LEVEL (Questions 10–17)
Question 10.
A patient presents with chest pain and the clinician orders a high-sensitivity troponin I (hs-TnI) level. The initial result at
presentation is within the normal reference range. The clinician repeats the troponin 3 hours later, and it is now significantly
elevated above the 99th percentile upper reference limit with a rising pattern. This serial troponin pattern is most consistent with:
A. Stable angina pectoris
B. Acute myocardial infarction (AMI)
C. Chronic kidney disease without acute cardiac injury
D. Musculoskeletal chest wall pain
Answer: B
Rationale: The diagnosis of acute myocardial infarction requires a rise and/or fall in cardiac troponin values with at least one
value above the 99th percentile upper reference limit, accompanied by clinical evidence of ischemia (symptoms, ECG changes, or
imaging findings). A single normal troponin does NOT rule out AMI in the early hours after symptom onset because troponin
release from necrotic myocytes takes time (typically 2–4 hours for initial elevation, peaking at 12–24 hours). Serial measurements
demonstrating a dynamic rising (or falling) pattern are essential for diagnosis. Stable angina (Option A) does not cause troponin
elevation. CKD (Option C) may cause chronically elevated troponin but without the acute dynamic rise/fall pattern.
Question 11.
A patient's lipid panel reveals the following: Total cholesterol 240 mg/dL, LDL 160 mg/dL, HDL 35 mg/dL, Triglycerides 225
mg/dL. Which of the following best characterizes this lipid profile?
A. Normal lipid profile within acceptable ranges
B. Isolated hypertriglyceridemia only
C. Mixed dyslipidemia with elevated LDL, low HDL, and elevated triglycerides, consistent with metabolic syndrome pattern
D. Isolated low HDL without other abnormalities
Answer: C
Rationale: This lipid profile demonstrates multiple abnormalities:
• Total cholesterol 240 mg/dL: Borderline high (≥240 = high)
• LDL 160 mg/dL: High (optimal <100; ≥160 = high)
• HDL 35 mg/dL: Low (<40 mg/dL in males, <50 mg/dL in females is a major cardiovascular risk factor)
• Triglycerides 225 mg/dL: High (≥200 = high)
This pattern of elevated LDL, low HDL, and hypertriglyceridemia is characteristic of atherogenic dyslipidemia commonly seen in
metabolic syndrome, type 2 diabetes, and insulin resistance. It confers significantly increased cardiovascular risk and typically
warrants lifestyle modification and statin therapy per ACC/AHA guidelines.
Question 12.
A patient with chronic kidney disease (CKD) has a glomerular filtration rate (GFR) of 25 mL/min/1.73 m². According to the
KDIGO staging system, this patient is classified as:
A. Stage 1 CKD (normal or high GFR ≥90)
B. Stage 2 CKD (mildly decreased GFR 60–89)
C. Stage 3 CKD (moderately decreased GFR 30–59)
D. Stage 4 CKD (severely decreased GFR 15–29)
Answer: D
Rationale: The KDIGO (Kidney Disease: Improving Global Outcomes) CKD staging system is based on GFR:
• Stage 1: GFR ≥90 with evidence of kidney damage (e.g., albuminuria)
• Stage 2: GFR 60–89 with evidence of kidney damage
• Stage 3a: GFR 45–59; Stage 3b: GFR 30–44
• Stage 4: GFR 15–29 (severely decreased)
• Stage 5: GFR <15 (kidney failure / end-stage renal disease)
A GFR of 25 mL/min/1.73 m² falls into Stage 4 CKD, indicating severely decreased kidney function. This patient requires close
nephrology follow-up, medication dose adjustments, and preparation for potential renal replacement therapy.
Question 13.
A D-dimer test is ordered for a patient with suspected deep vein thrombosis (DVT). The result is negative (below the threshold).
Given that the D-dimer test has high sensitivity (>95%) but low specificity, how should the clinician interpret this negative result in
a patient with a LOW pre-test probability (Wells score ≤1)?
,A. The negative D-dimer is inconclusive and the patient still requires a venous Doppler ultrasound
B. The negative D-dimer effectively rules out DVT in this low-risk patient, and no further imaging is required
C. The D-dimer is unreliable and should be repeated in 24 hours
D. A negative D-dimer confirms the presence of DVT
Answer: B
Rationale: The D-dimer test is a highly sensitive but nonspecific marker of fibrin degradation. Its primary clinical utility lies in
its high negative predictive value when used in patients with low or moderate pre-test probability of venous thromboembolism
(VTE). In a patient with a low Wells score (≤1) and a negative D-dimer, the combined negative predictive value exceeds 99%,
effectively ruling out DVT/PE without the need for imaging. However, a positive D-dimer is nonspecific (elevated in pregnancy,
surgery, malignancy, infection, advanced age) and requires confirmatory imaging. In HIGH pre-test probability patients, a negative
D-dimer is insufficient to rule out VTE, and imaging should proceed regardless.
Question 14.
A patient's liver function panel reveals: AST 450 U/L, ALT 520 U/L, Alkaline Phosphatase (ALP) 95 U/L, Total Bilirubin 1.2
mg/dL. This pattern is most consistent with:
A. Cholestatic liver disease (e.g., biliary obstruction)
B. Hepatocellular injury (e.g., acute viral hepatitis, drug-induced liver injury)
C. Isolated hemolysis
D. Normal liver function
Answer: B
Rationale: The pattern of liver enzyme elevation helps differentiate hepatocellular from cholestatic disease:
• Hepatocellular pattern: Disproportionate elevation of aminotransferases (AST and ALT) relative to ALP. ALT > AST is
typical of acute viral hepatitis and most drug-induced liver injuries. AST > ALT (ratio >2:1) suggests alcoholic liver
disease.
• Cholestatic pattern: Disproportionate elevation of ALP and gamma-glutamyl transferase (GGT) relative to
aminotransferases, suggesting biliary obstruction or cholestasis.
In this case, markedly elevated AST and ALT (both >10× upper limit of normal) with normal ALP and near-normal bilirubin
indicates acute hepatocellular injury.
Question 15.
A patient's CBC reveals: WBC 14,500/μL with 82% neutrophils, 10% bands, 5% lymphocytes, 3% monocytes. This WBC
differential pattern is most consistent with:
A. Viral infection
B. Acute bacterial infection with a "left shift"
C. Allergic reaction
D. Chronic lymphocytic leukemia
Answer: B
Rationale: This CBC demonstrates leukocytosis (WBC >11,000) with neutrophilia (82% neutrophils) and a "left shift" (10%
bands/immature neutrophils). The left shift indicates that the bone marrow is releasing immature neutrophils (bands) into the
circulation in response to an acute bacterial infection or significant inflammatory stimulus. Viral infections (Option A) typically
cause lymphocytosis or leukopenia. Allergic reactions (Option C) cause eosinophilia. CLL (Option D) causes marked
lymphocytosis with mature-appearing lymphocytes.
Question 16.
Which of the following best describes the clinical significance of the hemoglobin A1c (HbA1c) test?
A. It measures the patient's blood glucose level at the exact moment the blood was drawn
B. It reflects the average blood glucose concentration over the preceding 2–3 months based on glycosylation of hemoglobin in red
blood cells
C. It measures insulin production by the pancreatic beta cells
D. It detects the presence of ketones in the blood
Answer: B
Rationale: HbA1c measures the percentage of hemoglobin molecules that have been non-enzymatically glycosylated (bound to
glucose) over the lifespan of red blood cells (approximately 120 days). Because RBCs circulate for about 3 months, the HbA1c
reflects the weighted average blood glucose over the preceding 8–12 weeks, with the most recent 30 days contributing most
heavily. Diagnostic thresholds: Normal <5.7%, Prediabetes 5.7–6.4%, Diabetes ≥6.5%. Conditions affecting RBC turnover
(hemolytic anemia, recent transfusion, hemoglobinopathies) can falsely alter HbA1c results.
Question 17.
A clinician is evaluating a patient with suspected iron deficiency anemia. Which combination of laboratory findings is most
, consistent with this diagnosis?
A. Low serum iron, high TIBC, low ferritin, low transferrin saturation
B. High serum iron, low TIBC, high ferritin, high transferrin saturation
C. Normal serum iron, normal TIBC, normal ferritin, normal transferrin saturation
D. Low serum iron, low TIBC, high ferritin, low transferrin saturation
Answer: A
Rationale: The classic iron study pattern in iron deficiency anemia is:
• Low serum iron: Depleted circulating iron
• High Total Iron-Binding Capacity (TIBC): The liver produces more transferrin to maximize iron capture
• Low ferritin: Ferritin reflects iron stores; low ferritin (<15–30 ng/mL) is the most specific indicator of iron deficiency
• Low transferrin saturation: Calculated as (serum iron / TIBC) × 100; typically <15% in iron deficiency
Option B describes iron overload (hemochromatosis). Option D describes anemia of chronic disease/inflammation (low iron due to
sequestration, low TIBC, high ferritin as an acute-phase reactant).
HARD LEVEL (Questions 18–25)
Question 18.
A clinician is evaluating the utility of a new rapid antigen test for streptococcal pharyngitis. The test has a sensitivity of 85% and a
specificity of 95%. In a pediatric population where the prevalence of strep pharyngitis is 30%, what is the approximate positive
predictive value (PPV) of a positive test result?
A. Approximately 50%
B. Approximately 75%
C. Approximately 88%
D. Approximately 97%
Answer: C
Rationale: PPV depends on sensitivity, specificity, AND disease prevalence. Using a 2×2 table with a hypothetical population of
1,000 patients:
• Prevalence 30%: 300 have strep, 700 do not
• True Positives: 300 × 0.85 = 255
• False Negatives: 300 × 0.15 = 45
• True Negatives: 700 × 0.95 = 665
• False Positives: 700 × 0.05 = 35
• PPV = TP / (TP + FP) = 255 / (255 + 35) = ≈ 87.9% ≈ 88%
This demonstrates that even with good sensitivity and specificity, the PPV is influenced by prevalence. In a lower-prevalence
population, the PPV would be lower despite identical test characteristics.
Question 19.
A patient presents with acute dyspnea and the clinician suspects pulmonary embolism (PE). The patient has a Wells score of 6.5
(high pre-test probability). The D-dimer result is negative. What is the most appropriate next step?
A. Discharge the patient because the negative D-dimer rules out PE
B. Proceed with CT pulmonary angiography (CTPA) because a negative D-dimer is insufficient to exclude PE in a high pre-test
probability patient
C. Repeat the D-dimer in 48 hours
D. Order a ventilation-perfusion (V/Q) scan only if the D-dimer becomes positive
Answer: B
Rationale: The D-dimer test's clinical utility is highly dependent on pre-test probability. In patients with low or moderate pre-test
probability, a negative D-dimer effectively rules out PE (NPV >99%). However, in patients with high pre-test probability (Wells
score >4), the pre-test probability of PE is so high (approximately 40–60%) that even a negative D-dimer does not reduce the post-
test probability below a safe threshold to exclude PE. The false-negative rate of D-dimer in high-risk patients is clinically
unacceptable. Therefore, the clinician must proceed directly to definitive imaging (CTPA or V/Q scan) regardless of the D-dimer
result. This is a critical concept in diagnostic stewardship.
Question 20.
A patient with a mechanical mitral valve is on warfarin therapy. The target INR is 2.5–3.5. The patient's INR returns at 5.8 with no
active bleeding. According to current guidelines, the most appropriate management is:
A. Administer fresh frozen plasma (FFP) immediately and hold warfarin
B. Administer vitamin K 10 mg IV and hold warfarin
C. Hold warfarin, consider low-dose oral vitamin K (1–2.5 mg), and monitor INR closely; resume warfarin at a reduced dose when
INR returns to therapeutic range
ADVANCED ASSESSMENT: INTERPRETING
FINDINGS AND FORMULATING
DIFFERENTIAL DIAGNOSES
,TABLE OF CONTENTS
Part I: The Art of Assessment and Clinical Decision Making
Chapter 1. Clinical Decision Making: Assessment and Differential Diagnosis
Chapter 2. Diagnostic Studies
Chapter 3. Genomic Assessment: Interpreting Findings and Formulating Differential Diagnoses
Part II: Advanced Assessment and Differential Diagnosis by Body Regions and Systems
Chapter 4. Skin
Chapter 5. Head, Face, and Neck
Chapter 6. Eyes
Chapter 7. Ear, Nose, Mouth, and Throat
Chapter 8. Cardiac and Peripheral Vascular Systems
Chapter 9. Respiratory System
Chapter 10. Breasts
Chapter 11. Abdomen
Chapter 12. Genitourinary System
Chapter 13. Male Reproductive System
Chapter 14. Female Reproductive System
Chapter 15. Musculoskeletal System
Chapter 16. Neurological System
Chapter 17. Nonspecific Complaints
Chapter 18. Psychiatric Mental Health
Part III: Assessment and Differential Diagnosis in Special Patient Populations
Chapter 19. Pediatric Patients
Chapter 20. Pregnant Patients
Chapter 21. Assessment of Transgender and Gender-Diverse Adults
Chapter 22. Older Patients
Chapter 23. Persons With Disabilities
, Chapter 1. . Clinical Decision Making: Assessment and Differential Diagnosis
➢
Multiple Choice
Identify The Choice That Best Completes The Statement Or Answers The Question.
1. Which type of clinical decision-making is most reliable?
A. Intuitive
B. Analytical
C. Experiential
D. Augenblick
2. Which of the following is false? To obtain adequate history, health-care providers must be:
A. Methodical and systematic
B. Attentive to the patient’s verbal and nonverbal
Language
C. Able to accurately interpret the patient’s
responses
D. Adept at reading into the patient’s statements
3. Essential parts of a health history include all of the following except:
A. Chief complaint
B. History of the present illness
C. Current vital signs
D. All of the above are essential history
components
4. which of the following is false? While performing the physical examination, the examiner must be able to:
A. Differentiate between normal and abnormal findings
B. Recall knowledge of a range of conditions and their associated signs and
symptoms
C. Recognize how certain conditions affect the response to other
conditions
D. Foresee unpredictable findings
5. The following is the least reliable source of information for diagnostic statistics:
A. Evidence-based investigations
B. Primary reports of research
C. Estimation based on a provider’s
experience
D. Published meta-analyses
6. The following can be used to assist in sound clinical decision-making:
A. Algorithm published in a peer-reviewed journal
article
B. Clinical practice guidelines
C. Evidence-based research
D. All of the above
7. If a diagnostic study has high sensitivity, this indicates a:
A. High percentage of persons with the given condition will have an
abnormal
Result
B. Low percentage of persons with the given condition will have an
abnormal result
C. Low likelihood of normal result in persons without a given condition
D. None of the above
8. if a diagnostic study has high specificity, this indicates a:
A. Low percentage of healthy individuals will show a normal result
B. High percentage of healthy individuals will show a normal result
C. High percentage of individuals with a disorder will show a
normal result
D. Low percentage of individuals with a disorder will show an
abnormal
Result
9. a likelihood ratio above 1 indicates that a diagnostic test showing a:
A. Positive result is strongly associated with the disease
B. Negative result is strongly associated with absence of
the disease
C. Positive result is weakly associated with the disease
D. Negative result is weakly associated with absence of the
disease
, 10. which of the following clinical reasoning tools is defined as evidence-based resource based on
mathematical modeling to express the likelihood of a condition in select situations, settings, and/or
patients?
A. Clinical practice
guideline
B. Clinical decision rule
C. Clinical algorithm
Chapter 1: clinical reasoning, differential diagnosis, evidence-based practice, and symptom ana
Answer section
Multiple choice
1. Answer: b
Croskerry (2009) describes two major types of clinical diagnostic decision-making: intuitive and analytical.
Intuitive decision-making (similar to augenblink decision-making) is based on the experience and
intuition of the clinician and is less reliable andpaired with fairly common errors. In contrast, analytical
decision-making is based on careful consideration and has greater reliability with rare errors.
Pts: 1
2. Answer: d
To obtain adequate history, providers must be well organized, attentive to the patient’s verbal and
nonverbal language, and ableto accurately interpret the patient’s responses to questions. Rather than
reading into the patient’s statements, they clarify any areas of uncertainty.
Pts: 1
3. Answer: C
Vital signs are part of the physical examination portion of patient assessment, not part of the
health history.
Pts: 1
4. Answer: D
While performing the physical examination, the examiner must be able to differentiate between normal
and abnormal findings, recall knowledge of a range of conditions, including their associated signs and
symptoms, recognize how certain conditions affectthe response to other conditions, and distinguish the
relevance of varied abnormal findings.
Pts: 1
5. Answer: c
Sources for diagnostic statistics include textbooks, primary reports of research, and published meta-
analyses. Another source of statistics, the one that has been most widely used and available for application
to the reasoning process, is the estimation based ona provider’s experience, although these are rarely
accurate. Over the past decade, the availability of evidence on which to base clinical reasoning is improving,
and there is an increasing expectation that clinical reasoning be based on scientific evidence.
Evidence-based statistics are also increasingly being used to develop resources to facilitate clinical decision-making.
Pts: 1
6. Answer: d
To assist in clinical decision-making, a number of evidence-based resources have been developed to
assist the clinician. Resources, such as algorithms and clinical practice guidelines, assist in clinical
reasoning when properly applied.
Pts: 1
7. Answer: a
The sensitivity of a diagnostic study is the percentage of individuals with the target condition who show an
abnormal, or positive,result. A high sensitivity indicates that a greater percentage of persons with the given
condition will have an abnormal result.
Pts: 1
8. Answer: b
The specificity of a diagnostic study is the percentage of normal, healthy individuals who have a normal
result. The greater the specificity, the greater the percentage of individuals who will have negative, or
normal, results if they do not have the target condition.
Pts: 1
,9. Answer: a
The likelihood ratio is the probability that a positive test result will be associated with a person who has
the target condition and a negative result will be associated with a healthy person. A likelihood ratio above 1
indicates that a positive result is associated with the disease; a likelihood ratio less than 1 indicates that a
negative result is associated with an absence of the disease.
Pts: 1
10. Answer: b
Clinical decision (or prediction) rules provide another support for clinical reasoning. Clinical decision
rules are evidence-based resources that provide probabilistic statements regarding the likelihood that a
condition exists if certain variables are met with regard to the prognosis of patients with specific
findings. Decision rules use mathematical models and are specific to certain situations, settings,
and/or patient characteristics.
Pts: 1
,CHAPTER 2: DIAGNOSTIC STUDIES
SECTION A: MULTIPLE-CHOICE QUESTIONS (25 Questions)
EASY LEVEL (Questions 1–9)
Question 1.
What is the primary purpose of ordering diagnostic studies in advanced practice?
A. To replace the need for a thorough history and physical examination
B. To confirm or refute clinical hypotheses generated from the history and physical examination, thereby narrowing the differential
diagnosis
C. To order as many tests as possible to ensure no diagnosis is missed
D. To satisfy patient expectations regardless of clinical indication
Answer: B
Rationale: Diagnostic studies are an adjunct to—not a replacement for—the clinical encounter. The advanced practice clinician
formulates a differential diagnosis based on the history and physical examination, then selectively orders diagnostic tests to
confirm, refine, or exclude specific diagnoses. Indiscriminate test ordering ("shotgun approach") increases the risk of false-positive
results, unnecessary follow-up procedures, patient anxiety, and health care costs without improving diagnostic accuracy.
Question 2.
Which of the following best defines the "sensitivity" of a diagnostic test?
A. The proportion of patients without the disease who correctly test negative
B. The proportion of patients with the disease who correctly test positive (true positive rate)
C. The probability that a patient with a positive test actually has the disease
D. The probability that a patient with a negative test truly does not have the disease
Answer: B
Rationale: Sensitivity is the ability of a test to correctly identify individuals who HAVE the disease (true positive rate). It is
calculated as: Sensitivity = True Positives / (True Positives + False Negatives). A highly sensitive test is valuable for ruling
OUT disease when the result is negative (mnemonic: SnNOut — Sensitive test, Negative result, rules Out disease). Specificity
(Option A) is the true negative rate. Positive predictive value (Option C) and negative predictive value (Option D) describe post-
test probabilities.
Question 3.
Which of the following best defines the "specificity" of a diagnostic test?
A. The proportion of patients with the disease who correctly test positive
B. The ability of a test to correctly identify individuals who do NOT have the disease (true negative rate)
C. The likelihood that a positive test result is a true positive
D. The overall accuracy of the test across all populations
Answer: B
Rationale: Specificity is the ability of a test to correctly identify individuals who do NOT have the disease (true negative rate). It is
calculated as: Specificity = True Negatives / (True Negatives + False Positives). A highly specific test is valuable for ruling
IN disease when the result is positive (mnemonic: SpPIn — Specific test, Positive result, rules In disease). A test with high
specificity has a low false-positive rate.
Question 4.
A complete blood count (CBC) with differential is ordered for a patient presenting with fatigue and pallor. Which component of the
CBC is most directly relevant to evaluating for anemia?
A. White blood cell (WBC) count
B. Platelet count
C. Hemoglobin (Hgb) and hematocrit (Hct)
D. Mean platelet volume (MPV)
Answer: C
Rationale: Hemoglobin and hematocrit are the primary CBC parameters used to diagnose and classify anemia. Anemia is defined
as a hemoglobin level below the age- and sex-adjusted reference range (generally <13.5 g/dL in adult males, <12.0 g/dL in adult
females). The WBC count evaluates for infection, inflammation, or hematologic malignancy. Platelet count assesses
thrombocytopenia or thrombocytosis. MPV reflects platelet size and is relevant to platelet production disorders.
Question 5.
,Which laboratory test is the most sensitive initial screening test for thyroid dysfunction?
A. Free T4 (thyroxine)
B. Total T3 (triiodothyronine)
C. Thyroid-stimulating hormone (TSH)
D. Thyroid peroxidase antibodies (TPO-Ab)
Answer: C
Rationale: TSH is the single most sensitive screening test for thyroid dysfunction because of the logarithmic inverse relationship
between TSH and circulating thyroid hormone levels. Even small changes in free T4 produce large, amplified changes in TSH due
to the negative feedback loop of the hypothalamic-pituitary-thyroid axis. In primary hypothyroidism, TSH rises before free T4 falls
below the reference range (subclinical hypothyroidism). In primary hyperthyroidism, TSH is suppressed before free T4 rises above
the reference range. Free T4 and T3 are ordered as follow-up tests when TSH is abnormal.
Question 6.
A basic metabolic panel (BMP) includes all of the following EXCEPT:
A. Blood urea nitrogen (BUN)
B. Creatinine
C. Alanine aminotransferase (ALT)
D. Glucose
Answer: C
Rationale: The Basic Metabolic Panel (BMP) includes 8 tests: sodium, potassium, chloride, CO₂ (bicarbonate), BUN, creatinine,
glucose, and calcium. ALT is a liver enzyme included in the Comprehensive Metabolic Panel (CMP) or Hepatic Function Panel,
NOT the BMP. The CMP includes all 8 BMP tests plus 6 additional tests: total protein, albumin, alkaline phosphatase (ALP), ALT,
AST, and total bilirubin.
Question 7.
Which of the following urinalysis findings is most suggestive of a urinary tract infection (UTI)?
A. Specific gravity of 1.010
B. pH of 6.0
C. Positive leukocyte esterase and nitrites with microscopic pyuria (>10 WBCs/hpf)
D. Trace protein
Answer: C
Rationale: The classic urinalysis triad for UTI includes: (1) Positive leukocyte esterase (indicating the presence of WBC enzyme
from neutrophils), (2) Positive nitrites (indicating the presence of nitrate-reducing gram-negative bacteria such as E. coli), and
(3) Microscopic pyuria (>10 WBCs per high-power field). While isolated findings may be nonspecific, the combination of all
three has high positive predictive value for bacterial UTI. Trace protein and normal pH/specific gravity are nonspecific findings.
Question 8.
What does an elevated C-reactive protein (CRP) level indicate?
A. Specific diagnosis of rheumatoid arthritis
B. Acute or chronic systemic inflammation (nonspecific acute-phase reactant)
C. Bacterial infection exclusively
D. Liver failure
Answer: B
Rationale: CRP is a nonspecific acute-phase reactant synthesized by the liver in response to interleukin-6 (IL-6) and other
proinflammatory cytokines. It rises rapidly within 6–8 hours of an inflammatory stimulus and can be elevated in a wide range of
conditions: bacterial and viral infections, autoimmune diseases, tissue injury, malignancy, and cardiovascular disease. CRP does
NOT identify the specific cause or location of inflammation. High-sensitivity CRP (hs-CRP) is used for cardiovascular risk
stratification, while standard CRP is used for monitoring inflammatory and infectious conditions.
Question 9.
Which coagulation test is used to monitor warfarin (Coumadin) therapy?
A. Activated partial thromboplastin time (aPTT)
B. Prothrombin time (PT) and International Normalized Ratio (INR)
C. Bleeding time
D. D-dimer
Answer: B
Rationale: The PT/INR is the standard test for monitoring warfarin anticoagulation therapy. Warfarin inhibits vitamin K–
dependent clotting factors (II, VII, IX, X), which are measured by the PT. The INR standardizes PT results across different
laboratories and reagent sensitivities. The therapeutic INR range is typically 2.0–3.0 for most indications (e.g., atrial fibrillation,
,DVT/PE) and 2.5–3.5 for mechanical heart valves. The aPTT (Option A) monitors unfractionated heparin therapy. D-dimer
(Option D) is used to evaluate for venous thromboembolism.
MEDIUM LEVEL (Questions 10–17)
Question 10.
A patient presents with chest pain and the clinician orders a high-sensitivity troponin I (hs-TnI) level. The initial result at
presentation is within the normal reference range. The clinician repeats the troponin 3 hours later, and it is now significantly
elevated above the 99th percentile upper reference limit with a rising pattern. This serial troponin pattern is most consistent with:
A. Stable angina pectoris
B. Acute myocardial infarction (AMI)
C. Chronic kidney disease without acute cardiac injury
D. Musculoskeletal chest wall pain
Answer: B
Rationale: The diagnosis of acute myocardial infarction requires a rise and/or fall in cardiac troponin values with at least one
value above the 99th percentile upper reference limit, accompanied by clinical evidence of ischemia (symptoms, ECG changes, or
imaging findings). A single normal troponin does NOT rule out AMI in the early hours after symptom onset because troponin
release from necrotic myocytes takes time (typically 2–4 hours for initial elevation, peaking at 12–24 hours). Serial measurements
demonstrating a dynamic rising (or falling) pattern are essential for diagnosis. Stable angina (Option A) does not cause troponin
elevation. CKD (Option C) may cause chronically elevated troponin but without the acute dynamic rise/fall pattern.
Question 11.
A patient's lipid panel reveals the following: Total cholesterol 240 mg/dL, LDL 160 mg/dL, HDL 35 mg/dL, Triglycerides 225
mg/dL. Which of the following best characterizes this lipid profile?
A. Normal lipid profile within acceptable ranges
B. Isolated hypertriglyceridemia only
C. Mixed dyslipidemia with elevated LDL, low HDL, and elevated triglycerides, consistent with metabolic syndrome pattern
D. Isolated low HDL without other abnormalities
Answer: C
Rationale: This lipid profile demonstrates multiple abnormalities:
• Total cholesterol 240 mg/dL: Borderline high (≥240 = high)
• LDL 160 mg/dL: High (optimal <100; ≥160 = high)
• HDL 35 mg/dL: Low (<40 mg/dL in males, <50 mg/dL in females is a major cardiovascular risk factor)
• Triglycerides 225 mg/dL: High (≥200 = high)
This pattern of elevated LDL, low HDL, and hypertriglyceridemia is characteristic of atherogenic dyslipidemia commonly seen in
metabolic syndrome, type 2 diabetes, and insulin resistance. It confers significantly increased cardiovascular risk and typically
warrants lifestyle modification and statin therapy per ACC/AHA guidelines.
Question 12.
A patient with chronic kidney disease (CKD) has a glomerular filtration rate (GFR) of 25 mL/min/1.73 m². According to the
KDIGO staging system, this patient is classified as:
A. Stage 1 CKD (normal or high GFR ≥90)
B. Stage 2 CKD (mildly decreased GFR 60–89)
C. Stage 3 CKD (moderately decreased GFR 30–59)
D. Stage 4 CKD (severely decreased GFR 15–29)
Answer: D
Rationale: The KDIGO (Kidney Disease: Improving Global Outcomes) CKD staging system is based on GFR:
• Stage 1: GFR ≥90 with evidence of kidney damage (e.g., albuminuria)
• Stage 2: GFR 60–89 with evidence of kidney damage
• Stage 3a: GFR 45–59; Stage 3b: GFR 30–44
• Stage 4: GFR 15–29 (severely decreased)
• Stage 5: GFR <15 (kidney failure / end-stage renal disease)
A GFR of 25 mL/min/1.73 m² falls into Stage 4 CKD, indicating severely decreased kidney function. This patient requires close
nephrology follow-up, medication dose adjustments, and preparation for potential renal replacement therapy.
Question 13.
A D-dimer test is ordered for a patient with suspected deep vein thrombosis (DVT). The result is negative (below the threshold).
Given that the D-dimer test has high sensitivity (>95%) but low specificity, how should the clinician interpret this negative result in
a patient with a LOW pre-test probability (Wells score ≤1)?
,A. The negative D-dimer is inconclusive and the patient still requires a venous Doppler ultrasound
B. The negative D-dimer effectively rules out DVT in this low-risk patient, and no further imaging is required
C. The D-dimer is unreliable and should be repeated in 24 hours
D. A negative D-dimer confirms the presence of DVT
Answer: B
Rationale: The D-dimer test is a highly sensitive but nonspecific marker of fibrin degradation. Its primary clinical utility lies in
its high negative predictive value when used in patients with low or moderate pre-test probability of venous thromboembolism
(VTE). In a patient with a low Wells score (≤1) and a negative D-dimer, the combined negative predictive value exceeds 99%,
effectively ruling out DVT/PE without the need for imaging. However, a positive D-dimer is nonspecific (elevated in pregnancy,
surgery, malignancy, infection, advanced age) and requires confirmatory imaging. In HIGH pre-test probability patients, a negative
D-dimer is insufficient to rule out VTE, and imaging should proceed regardless.
Question 14.
A patient's liver function panel reveals: AST 450 U/L, ALT 520 U/L, Alkaline Phosphatase (ALP) 95 U/L, Total Bilirubin 1.2
mg/dL. This pattern is most consistent with:
A. Cholestatic liver disease (e.g., biliary obstruction)
B. Hepatocellular injury (e.g., acute viral hepatitis, drug-induced liver injury)
C. Isolated hemolysis
D. Normal liver function
Answer: B
Rationale: The pattern of liver enzyme elevation helps differentiate hepatocellular from cholestatic disease:
• Hepatocellular pattern: Disproportionate elevation of aminotransferases (AST and ALT) relative to ALP. ALT > AST is
typical of acute viral hepatitis and most drug-induced liver injuries. AST > ALT (ratio >2:1) suggests alcoholic liver
disease.
• Cholestatic pattern: Disproportionate elevation of ALP and gamma-glutamyl transferase (GGT) relative to
aminotransferases, suggesting biliary obstruction or cholestasis.
In this case, markedly elevated AST and ALT (both >10× upper limit of normal) with normal ALP and near-normal bilirubin
indicates acute hepatocellular injury.
Question 15.
A patient's CBC reveals: WBC 14,500/μL with 82% neutrophils, 10% bands, 5% lymphocytes, 3% monocytes. This WBC
differential pattern is most consistent with:
A. Viral infection
B. Acute bacterial infection with a "left shift"
C. Allergic reaction
D. Chronic lymphocytic leukemia
Answer: B
Rationale: This CBC demonstrates leukocytosis (WBC >11,000) with neutrophilia (82% neutrophils) and a "left shift" (10%
bands/immature neutrophils). The left shift indicates that the bone marrow is releasing immature neutrophils (bands) into the
circulation in response to an acute bacterial infection or significant inflammatory stimulus. Viral infections (Option A) typically
cause lymphocytosis or leukopenia. Allergic reactions (Option C) cause eosinophilia. CLL (Option D) causes marked
lymphocytosis with mature-appearing lymphocytes.
Question 16.
Which of the following best describes the clinical significance of the hemoglobin A1c (HbA1c) test?
A. It measures the patient's blood glucose level at the exact moment the blood was drawn
B. It reflects the average blood glucose concentration over the preceding 2–3 months based on glycosylation of hemoglobin in red
blood cells
C. It measures insulin production by the pancreatic beta cells
D. It detects the presence of ketones in the blood
Answer: B
Rationale: HbA1c measures the percentage of hemoglobin molecules that have been non-enzymatically glycosylated (bound to
glucose) over the lifespan of red blood cells (approximately 120 days). Because RBCs circulate for about 3 months, the HbA1c
reflects the weighted average blood glucose over the preceding 8–12 weeks, with the most recent 30 days contributing most
heavily. Diagnostic thresholds: Normal <5.7%, Prediabetes 5.7–6.4%, Diabetes ≥6.5%. Conditions affecting RBC turnover
(hemolytic anemia, recent transfusion, hemoglobinopathies) can falsely alter HbA1c results.
Question 17.
A clinician is evaluating a patient with suspected iron deficiency anemia. Which combination of laboratory findings is most
, consistent with this diagnosis?
A. Low serum iron, high TIBC, low ferritin, low transferrin saturation
B. High serum iron, low TIBC, high ferritin, high transferrin saturation
C. Normal serum iron, normal TIBC, normal ferritin, normal transferrin saturation
D. Low serum iron, low TIBC, high ferritin, low transferrin saturation
Answer: A
Rationale: The classic iron study pattern in iron deficiency anemia is:
• Low serum iron: Depleted circulating iron
• High Total Iron-Binding Capacity (TIBC): The liver produces more transferrin to maximize iron capture
• Low ferritin: Ferritin reflects iron stores; low ferritin (<15–30 ng/mL) is the most specific indicator of iron deficiency
• Low transferrin saturation: Calculated as (serum iron / TIBC) × 100; typically <15% in iron deficiency
Option B describes iron overload (hemochromatosis). Option D describes anemia of chronic disease/inflammation (low iron due to
sequestration, low TIBC, high ferritin as an acute-phase reactant).
HARD LEVEL (Questions 18–25)
Question 18.
A clinician is evaluating the utility of a new rapid antigen test for streptococcal pharyngitis. The test has a sensitivity of 85% and a
specificity of 95%. In a pediatric population where the prevalence of strep pharyngitis is 30%, what is the approximate positive
predictive value (PPV) of a positive test result?
A. Approximately 50%
B. Approximately 75%
C. Approximately 88%
D. Approximately 97%
Answer: C
Rationale: PPV depends on sensitivity, specificity, AND disease prevalence. Using a 2×2 table with a hypothetical population of
1,000 patients:
• Prevalence 30%: 300 have strep, 700 do not
• True Positives: 300 × 0.85 = 255
• False Negatives: 300 × 0.15 = 45
• True Negatives: 700 × 0.95 = 665
• False Positives: 700 × 0.05 = 35
• PPV = TP / (TP + FP) = 255 / (255 + 35) = ≈ 87.9% ≈ 88%
This demonstrates that even with good sensitivity and specificity, the PPV is influenced by prevalence. In a lower-prevalence
population, the PPV would be lower despite identical test characteristics.
Question 19.
A patient presents with acute dyspnea and the clinician suspects pulmonary embolism (PE). The patient has a Wells score of 6.5
(high pre-test probability). The D-dimer result is negative. What is the most appropriate next step?
A. Discharge the patient because the negative D-dimer rules out PE
B. Proceed with CT pulmonary angiography (CTPA) because a negative D-dimer is insufficient to exclude PE in a high pre-test
probability patient
C. Repeat the D-dimer in 48 hours
D. Order a ventilation-perfusion (V/Q) scan only if the D-dimer becomes positive
Answer: B
Rationale: The D-dimer test's clinical utility is highly dependent on pre-test probability. In patients with low or moderate pre-test
probability, a negative D-dimer effectively rules out PE (NPV >99%). However, in patients with high pre-test probability (Wells
score >4), the pre-test probability of PE is so high (approximately 40–60%) that even a negative D-dimer does not reduce the post-
test probability below a safe threshold to exclude PE. The false-negative rate of D-dimer in high-risk patients is clinically
unacceptable. Therefore, the clinician must proceed directly to definitive imaging (CTPA or V/Q scan) regardless of the D-dimer
result. This is a critical concept in diagnostic stewardship.
Question 20.
A patient with a mechanical mitral valve is on warfarin therapy. The target INR is 2.5–3.5. The patient's INR returns at 5.8 with no
active bleeding. According to current guidelines, the most appropriate management is:
A. Administer fresh frozen plasma (FFP) immediately and hold warfarin
B. Administer vitamin K 10 mg IV and hold warfarin
C. Hold warfarin, consider low-dose oral vitamin K (1–2.5 mg), and monitor INR closely; resume warfarin at a reduced dose when
INR returns to therapeutic range
